Other
Accounts Receivable, Allowance for Credit Loss, Writeoff
Analysis
StatementIncome Statement
SectionOther
Metric ID:
other_allowance_for_doubtful_accounts_receivable_write_offsBusiness Segments
| Segment | FY'26 |
|---|---|
| North American Pharmaceutical | $483M |
| Total | — |
All segment values are derived from annual filings.
U.S. Pharmaceutical was previously reported and has since been discontinued or reclassified. Only currently active segments are shown in the chart.
